M. Baens

The pathogenesis of MALT lymphomas: where do we stand?

H. Noels, C. Wolf‐peeters, X. Sagaert, 2007, Leukemia.

Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-κB Activation

P. Van Loo, P. Lucas, H. Noels, 2011, Science.

MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells

C. Wolf‐peeters, X. Sagaert, M. Laurent, 2006, Modern Pathology.

A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.

J. J. van den Oord, C. de Wolf‐Peeters, H. Degreef, 2001, Cancer research.

DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma

K. Naresh, T. Crook, N. Syed, 2010, British Journal of Cancer.